Guido Freckmann
Overview
Explore the profile of Guido Freckmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
181
Citations
2202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Link M, Eichenlaub M, Waldenmaier D, Wehrstedt S, Pleus S, Jendrike N, et al.
J Diabetes Sci Technol
. 2025 Feb;
:19322968251317526.
PMID: 39989334
Background: In continuous glucose monitoring (CGM) system performance studies, it is common to implement specific procedures for manipulating the participants' blood glucose (BG) levels during the collection of comparator BG...
2.
Spartano N, Prescott B, Walker M, Shi E, Venkatesan G, Fei D, et al.
J Diabetes Sci Technol
. 2025 Feb;
:19322968251315171.
PMID: 39936548
Background: Clinical interpretation of continuous glucose monitoring (CGM) data for people without diabetes has not been well established. This study aimed to investigate concordance among CGM experts in recommending clinical...
3.
Eichenlaub M, Waldenmaier D, Wehrstedt S, Pleus S, Link M, Jendrike N, et al.
J Diabetes Sci Technol
. 2025 Feb;
:19322968251315459.
PMID: 39902649
Background: The performance of continuous glucose monitoring (CGM) systems is difficult to compare due to different study designs and a lack of head-to-head studies. This study evaluated the performance of...
4.
Pleus S, Eichenlaub M, Eriksson Boija E, Fokkert M, Hinzmann R, Jendle J, et al.
J Diabetes Sci Technol
. 2024 Nov;
:19322968241296097.
PMID: 39540398
Metrics derived from continuous glucose monitoring (CGM) systems are often discordant between systems. A major cause is that CGM systems are not standardized; they use various algorithms and calibration methods,...
5.
Shaw J, Bannuru R, Beach L, ElSayed N, Freckmann G, Fuzery A, et al.
Diabetes Care
. 2024 Oct;
47(12):2062-2075.
PMID: 39452893
Continuous glucose monitoring (CGM) systems provide frequent glucose measurements in interstitial fluid and have been used widely in ambulatory settings for diabetes management. During the coronavirus disease 2019 (COVID-19) pandemic,...
6.
Klonoff D, Freckmann G, Pleus S, Kovatchev B, Kerr D, Tse C, et al.
J Diabetes Sci Technol
. 2024 Oct;
18(6):1346-1361.
PMID: 39369312
Introduction: An error grid compares measured versus reference glucose concentrations to assign clinical risk values to observed errors. Widely used error grids for blood glucose monitors (BGMs) have limited value...
7.
Snel T, Reinhardt S, Koenig H, Pleus S, Freckmann G
Diabetes Ther
. 2024 Sep;
15(11):2429-2441.
PMID: 39347901
Introduction: The shortage of general practitioners (GPs) and the increasing prevalence of type 2 diabetes create significant pressure on primary healthcare services. To enable that medical services are available to...
8.
Kulzer B, Freckmann G, Ziegler R, Schnell O, Glatzer T, Heinemann L
J Diabetes Sci Technol
. 2024 Aug;
18(5):1052-1060.
PMID: 39158988
Nocturnal hypoglycemia is a common acute complication of people with diabetes on insulin therapy. In particular, the inability to control glucose levels during sleep, the impact of external factors such...
9.
Mader J, Waldenmaier D, Mueller-Hoffmann W, Mueller K, Angstmann M, Vogt G, et al.
J Diabetes Sci Technol
. 2024 Aug;
18(5):1044-1051.
PMID: 39158986
Background: In this multicenter study, performance of a novel continuous glucose monitoring (CGM) system was evaluated. Methods: Adult participants with diabetes were included in the study. They each wore three...
10.
Eichenlaub M, Oter S, Waldenmaier D, Kulzer B, Heinemann L, Ziegler R, et al.
J Diabetes Sci Technol
. 2024 Aug;
18(5):1035-1043.
PMID: 39158983
Background: Nocturnal hypoglycaemia is a burden for people with diabetes, particularly when treated with multiple daily injections (MDI) therapy. However, the characteristics of nocturnal hypoglycaemic events in this patient group...